AbbVie

E184183

AbbVie is a global biopharmaceutical company known for developing and marketing innovative therapies in areas such as immunology, oncology, and neuroscience.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (2)

Label Occurrences
AbbVie canonical 10
ABBV 1

Statements (50)

Predicate Object
instanceOf biopharmaceutical company
multinational corporation
public company
acquired Allergan
acquiredFrom Allergan shareholders
acquisitionDate 2020-05-08
CEO Richard A. Gonzalez
chairperson Richard A. Gonzalez
country United States of America
surface form: United States
focusArea aesthetics
eye care
immunology
neuroscience
oncology
virology
women's health
foundedBy Abbott Laboratories
foundingDate 2013-01-02
headquartersLocation North Chicago, Illinois
industry biotechnology
pharmaceuticals
ISIN US00287Y1091
legalForm corporation
memberOf S&P 500 Index
surface form: S&P 500
notableProduct Botox (therapeutic and cosmetic)
Humira
Imbruvica
Juvederm
Rinvoq
Skyrizi
Venclexta
numberOfEmployees over 50,000
operatesIn Africa
Asia
Europe
Latin America
Middle East
North America
parentCompanyAtFounding Abbott Laboratories
researchFocus autoimmune diseases
hematologic malignancies
inflammatory bowel disease
neurodegenerative diseases
psoriasis
rheumatoid arthritis
solid tumors
separatedFrom Abbott Laboratories
stockExchange New York Stock Exchange
tickerSymbol AbbVie self-linksurface differs
surface form: ABBV
website https://www.abbvie.com

Referenced by (11)

Full triples — surface form annotated when it differs from this entity's canonical label.

Imbruvica isMarketedBy AbbVie
Calico hasCollaboration AbbVie
AbbVie tickerSymbol AbbVie self-linksurface differs
this entity surface form: ABBV